Orum Therapeutics Email Formats
Biotechnology Research • 
Daejeon, Korea & Lexington, United States • 51-100 Employees
Orum Therapeutics Email Formats
Orum Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@orumrx.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@orumrx.com | 50% |
{first name}.{last name} | john.doe@orumrx.com | 50% |
Key Contacts at Orum Therapeutics
Joanne Lim
Associate Director, Immunology
Kyuri A. Kim
Associate Director, Business Development
Sarah Mowbray
Assistant Director Of Project And Alliance Management
Dennise Greensmith
Director Clinical Operations
Adam Boutin
Director In Vivo Pharmacology
Min Soo Kim
Director, Antibody Engineering
Christine O’Day
Senior Director, Intellectual Property
Liegh Nguyen
Executive Director, Program And Alliance Management
Company overview
| Headquarters | Daejeon, Korea & Lexington, United States |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Cancer, Oncology, Drug Development, TPD, ADC, Antibody Drug Conjugation, Targeted Protein Degradation |
| Founded | 2016 |
| Employees | 51-100 |
| Socials |
About Orum Therapeutics
Orum Therapeutics (KRX: 475830) is a public biotechnology company developing TPD2®, a novel class of targeted protein degradation therapeutics. Also known as degrader-antibody conjugates (DACs), these therapeutics combine the precision of antibodies with Orum's novel degrader payloads to break down disease-causing proteins inside specific cells. By enabling the selective degradation of previously “undruggable” targets, Orum is working to improve the effectiveness, safety, and reach of targeted protein degradation. The company’s lead programs target GSPT1, and it is also advancing next-generation payloads to expand the potential of its DAC pipeline. In parallel, Orum is developing proprietary linker technologies to increase the flexibility and precision of future DAC programs. With headquarters in Daejeon, South Korea, and Lexington, Massachusetts, U.S., Orum is globally positioned to deliver first-in-class cancer therapies for patients with hard-to-treat diseases. For more information, visit www.orumrx.com.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Orum Therapeutics has 21 employees across 9 departments.
Departments
Number of employees
Funding Data
Orum Therapeutics has never raised funding before.
Orum Therapeutics Tech Stack
Discover the technologies and tools that power Orum Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Development
JavaScript libraries
Security
Ecommerce
Hosting
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
United Kingdom
Frequently asked questions
4.8
40,000 users
